{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:10:46Z","timestamp":1790982646097,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health\/National Heart, Lung, and Blood Institute","award":["N01-HC-25195"],"award-info":[{"award-number":["N01-HC-25195"]}]}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.atherosclerosis.2013.01.046","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T19:54:52Z","timestamp":1361217292000},"page":"230-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study"],"prefix":"10.1016","volume":"228","author":[{"given":"Sander J.","family":"Robins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asya","family":"Lyass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Brocia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.ATV.0000118278.21719.17","article-title":"Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib","volume":"24","author":"Clark","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib2","doi-asserted-by":"crossref","first-page":"26898","DOI":"10.1074\/jbc.M010708200","article-title":"The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein","volume":"276","author":"Settasatian","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib3","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1172\/JCI119050","article-title":"Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes","volume":"98","author":"Jiang","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib4","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/CIRCULATIONAHA.109.872705","article-title":"Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community","volume":"120","author":"Vasan","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.109.875013","article-title":"Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study","volume":"121","author":"Ritsch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.amjcard.2010.03.057","article-title":"On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy \u2013 thrombolysis in myocardial infarction 22 [PROVE-IT-TIMI 22] Study)","volume":"106","author":"Khera","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1194\/jlr.M800414-JLR200","article-title":"PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study","volume":"50","author":"Schlitt","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib10","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/01.ATV.0000094433.98445.7F","article-title":"High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease","volume":"23","author":"Schlitt","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCULATIONAHA.109.912519","article-title":"Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility","volume":"122","author":"Vergeer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a112813","article-title":"An investigation of coronary heart disease in families: the Framingham Offspring Study","volume":"110","author":"Kannel","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib13","series-title":"Statistical analysis of epidemiologic data","author":"Selvin","year":"1996"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib16","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1009744","article-title":"Safety of anacetrapib in patients with or at high risk for coronary heart disease","volume":"363","author":"Cannon","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib17","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.CIR.0000141730.65972.95","article-title":"Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women","volume":"110","author":"Boekholdt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehm062","article-title":"High plasma cholesteryl ester transfer protein may favour reduced incidence of cardiovascular events in men with low triglycerides","volume":"28","author":"Borggreve","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.atherosclerosis.2011.03.020","article-title":"High plasma cholesteryl ester transfer but not mass predicts incident cardiovascular disease: a nested case-control study","volume":"217","author":"Kappelle","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib20","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jacc.2007.06.052","article-title":"High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction","volume":"50","author":"Zeller","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2009.04.011","article-title":"Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography","volume":"207","author":"Cavusoglu","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00125-005-0088-0","article-title":"Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus","volume":"49","author":"deVries","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2007.04.046","article-title":"Low phospholipid transfer protein is a risk factor for peripheral atherosclerosis","volume":"196","author":"Schgoer","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI5578","article-title":"Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels","volume":"103","author":"Jiang","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib25","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.ATV.20.4.1082","article-title":"Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice","volume":"20","author":"van Haperen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1096-4959(01)00297-4","article-title":"Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in pre\u03b2-HDL generation","volume":"128","author":"Jaari","year":"2001","journal-title":"Comp Biochem Physiol Part B"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/89977","article-title":"Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency","volume":"7","author":"Jiang","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbalip.2004.12.011","article-title":"Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice","volume":"1733","author":"Schlitt","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbadis.2005.09.002","article-title":"Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease","volume":"1762","author":"Cheung","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib30","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1194\/jlr.M300511-JLR200","article-title":"Lipoprotein cholesteryl ester production, transfer, and output in\u00a0vivo in humans","volume":"45","author":"Schwartz","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.01.046_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2006.05.036","article-title":"CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion","volume":"191","author":"Harada","year":"2007","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T16:22:59Z","timestamp":1539879779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0021915013001123"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.046","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}